Trupanion (NASDAQ:TRUP) Stock Rating Upgraded by Cantor Fitzgerald

Key Points

• Cantor Fitzgerald has upgraded Trupanion (NASDAQ:TRUP) to a "hold" rating, reflecting a shift in sentiment towards the stock.
• Three investment analysts rated Trupanion with a "hold," while three others rated it as a "buy," giving it a consensus rating of "Moderate Buy" and a price target of $54.17.
• Trupanion reported a 12.3% year-over-year revenue growth in its latest quarter, exceeding analysts' earnings expectations with an EPS of $0.22.

Trupanion (NASDAQ:TRUP - Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald to a "hold" rating in a report released on Wednesday,Zacks.com reports. Cantor Fitzgerald also issued estimates for Trupanion's FY2025 earnings at $0.43 EPS and FY2026 earnings at $0.23 EPS.

Other equities analysts have also recently issued research reports about the company. Piper Sandler upped their price target on Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a report on Friday, August 8th. Stifel Nicolaus increased their target price on Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a report on Friday, August 8th. Finally, Lake Street Capital dropped their price target on Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Trupanion has a consensus rating of "Moderate Buy" and a consensus target price of $54.17.

Trupanion Stock Down 1.8%

TRUP stock traded down $0.8550 on Wednesday, hitting $47.7350. 119,199 shares of the company's stock were exchanged, compared to its average volume of 601,683. Trupanion has a 12-month low of $31.00 and a 12-month high of $57.90. The firm has a 50 day moving average price of $51.21 and a two-hundred day moving average price of $44.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.69 and a current ratio of 1.69. The stock has a market cap of $2.05 billion, a P/E ratio of 183.65 and a beta of 1.78.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.25. The business had revenue of $353.56 million for the quarter, compared to the consensus estimate of $346.73 million. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The company's quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.14) EPS. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts expect that Trupanion will post 0.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 2,534 shares of the firm's stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $48.31, for a total transaction of $122,417.54. Following the transaction, the chief financial officer owned 3,545 shares of the company's stock, valued at approximately $171,258.95. This trade represents a 41.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO John R. Gallagher sold 4,000 shares of the firm's stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $47.90, for a total value of $191,600.00. Following the transaction, the chief operating officer directly owned 26,966 shares in the company, valued at approximately $1,291,671.40. The trade was a 12.92% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,562 shares of company stock worth $361,430. 5.42% of the stock is owned by insiders.

Hedge Funds Weigh In On Trupanion

Several hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. grew its holdings in shares of Trupanion by 458.3% during the fourth quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider's stock worth $7,620,000 after buying an additional 129,782 shares during the last quarter. Wells Fargo & Company MN lifted its position in shares of Trupanion by 44.1% during the 4th quarter. Wells Fargo & Company MN now owns 15,798 shares of the financial services provider's stock valued at $761,000 after acquiring an additional 4,836 shares during the period. Russell Investments Group Ltd. lifted its position in shares of Trupanion by 41.8% during the 4th quarter. Russell Investments Group Ltd. now owns 9,172 shares of the financial services provider's stock valued at $442,000 after acquiring an additional 2,706 shares during the period. Invesco Ltd. lifted its stake in Trupanion by 122.0% in the 4th quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider's stock valued at $10,925,000 after buying an additional 124,549 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Trupanion in the 4th quarter valued at approximately $593,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.